Duplicate Detection Will Advance with Technology: Yet Underreporting Remains the Core Challenge

Abstract

Get full access to this article

View all access options for this article.

References

Pathak

Rasaili

Barma

, et al. Establishment of a drug information unit and pharmacovigilance cell in a Provincial Hospital of Nepal: implementation of the 2015 hospital pharmacy service guidelines. Hosp Pharm. Published online January 4, 2025. doi:10.1177/00185787241306689

Mishra

Gupta

. Leveraging generative AI for drug safety and pharmacovigilance. Curr Rev Clin Exp Pharmacol. 2025;20(2):89-97. doi:10.2174/0127724328311400240823062829

Nagar

Gobburu

Chakravarty

. Artificial intelligence in pharmacovigilance: advancing drug safety monitoring and regulatory integration. Ther Adv Drug Saf. 2025;16:1-16. doi:10.1177/20420986251361435

Shalviri

Mohebbi

Mirbaha

, et al. Improving adverse drug event reporting by healthcare professionals. Cochrane Database Syst Rev. 2024;10(10):CD012594. doi:10.1002/14651858.CD012594.pub2

Rieder

Belančić

. Past, present and future of drug safety: editorial. Br J Clin Pharmacol. 2024;90(8):1760-1762. doi:10.1111/bcp.16140